Raymond James Trust N.A. Sells 115 Shares of Humana Inc. (NYSE:HUM)

Raymond James Trust N.A. trimmed its position in shares of Humana Inc. (NYSE:HUM) by 0.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 12,007 shares of the insurance provider’s stock after selling 115 shares during the quarter. Raymond James Trust N.A.’s holdings in Humana were worth $3,803,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of HUM. Advisors Asset Management Inc. increased its position in shares of Humana by 4.5% during the first quarter. Advisors Asset Management Inc. now owns 5,370 shares of the insurance provider’s stock valued at $1,862,000 after acquiring an additional 230 shares in the last quarter. Lazard Asset Management LLC boosted its stake in Humana by 8.2% during the 1st quarter. Lazard Asset Management LLC now owns 406,993 shares of the insurance provider’s stock valued at $141,110,000 after purchasing an additional 30,778 shares during the last quarter. Bellevue Group AG boosted its stake in Humana by 34.9% during the 1st quarter. Bellevue Group AG now owns 135,541 shares of the insurance provider’s stock valued at $46,995,000 after purchasing an additional 35,069 shares during the last quarter. Ceeto Capital Group LLC increased its holdings in shares of Humana by 30.6% in the 1st quarter. Ceeto Capital Group LLC now owns 2,560 shares of the insurance provider’s stock worth $890,000 after purchasing an additional 600 shares in the last quarter. Finally, Steadfast Capital Management LP purchased a new position in shares of Humana in the first quarter worth $158,813,000. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on HUM shares. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a research report on Tuesday, October 8th. TD Cowen raised their price target on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. UBS Group reduced their price target on shares of Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, October 4th. JPMorgan Chase & Co. increased their price objective on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research report on Wednesday, August 21st. Finally, Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Stock Up 0.8 %

Shares of HUM stock opened at $298.11 on Friday. The stock’s fifty day moving average price is $276.83 and its 200 day moving average price is $330.64. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18. The company has a market cap of $35.90 billion, a price-to-earnings ratio of 26.40, a price-to-earnings-growth ratio of 2.33 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, research analysts expect that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.19%. Humana’s dividend payout ratio is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.